Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.
Joseph D. Dougherty, PhD discusses genetic compounds’ ability to clear amyloid-β from the brain in patients with Alzheimer disease.
Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.
GAPNA reviews studies on the links between dementia and cardiometabolic multimorbidity, atrial cardiopathy, and cardiovascular disease in midlife.
Drs Yuki Sakai, MD, PhD, and Saori C Tanaka, PhD, discuss using computational theory and experimental validation to identify the underlying mechanism of obsessive-compulsive disorder.
Aduhelm, a monoclonal antibody that targets amyloid-beta, is covered under Medicare for beneficiaries enrolled in clinical trials.
A 22-year-old man presents to the outpatient office following an overdose of antihistamines and alcohol. He was feeling overwhelmed trying to transition to in-person classes at the university after taking online classes during the COVID-19 lockdown.
We are proud to introduce an exciting new future for Psychiatry Advisor, one of the many websites in Haymarket Medical Network’s suite of clinical resources. Although the fresh new look is a welcome change, peek beneath the surface and you’ll see that we’ve also modernized our approach to providing the relevant and timely clinical content…
Looking at stress and university students during the COVID-19 pandemic.
The most common symptoms of monkeypox that have neurologic origins may also be related to infectious disease overall.